Asylia Therapeutics

About:

Asylia Therapeutics is a biotech company focused on novel immune-modulating therapies for autoimmune, cancer, and infectious diseases.

Website: https://asyliatx.com

Twitter/X: asyliatx

Top Investors: Sporos Bioventures

Description:

Asylia Therapeutics is a biotech company focused on novel immune-modulating therapies for autoimmune, cancer, and infectious diseases. The company's platform centers on a drug pipeline capable of modulating antigen presentation to the immune system which has produced unprecedented anti-tumor responses across multiple cancer models. Asylia Therapeutics was founded in 2019 in Houston, Texas.